About
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
Mar 27 2026
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Feb 26 2026
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 5 2026
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nov 25 2025
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Financials
Revenue
$0
Market Cap
$385.42 M
EPS
-2.01
Translate